T2 Biosystems (FRA:3T2) Total Liabilities : €57.53 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is T2 Biosystems Total Liabilities?

T2 Biosystems's Total Liabilities for the quarter that ended in Mar. 2024 was €57.53 Mil.

T2 Biosystems's quarterly Total Liabilities declined from Sep. 2023 (€58.58 Mil) to Dec. 2023 (€57.62 Mil) and declined from Dec. 2023 (€57.62 Mil) to Mar. 2024 (€57.53 Mil).

T2 Biosystems's annual Total Liabilities increased from Dec. 2021 (€65.00 Mil) to Dec. 2022 (€69.84 Mil) but then declined from Dec. 2022 (€69.84 Mil) to Dec. 2023 (€57.62 Mil).

T2 Biosystems Total Liabilities Historical Data

The historical data trend for T2 Biosystems's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

T2 Biosystems Total Liabilities Chart

T2 Biosystems Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

56.24

57.83

65.00

69.84

57.62

T2 Biosystems Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															77.17	67.89	58.58	57.62	57.53

T2 Biosystems Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

T2 Biosystems's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	51.491	+	(6.05	+	0.0010000000000026
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0.076	+	0)
	=	57.62

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	31.909	-	-25.709
	=	57.62

T2 Biosystems's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	51.756	+	(5.686	+	-0.00099999999999682
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0.085	+	0)
	=	57.53

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	22.775	-	-34.751
	=	57.53

T2 Biosystems Total Liabilities Related Terms

Thank you for viewing the detailed overview of T2 Biosystems's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

T2 Biosystems (FRA:3T2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » T2 Biosystems Inc (FRA:3T2) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

TTOO:USA

Address

101 Hartwell Avenue, Lexington, MA, USA, 02421

Website

https://www.t2biosystems.com

T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. The company's core technology is T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood. T2MR technology enables the T2Dx system, which is fully automated from patient sample to result for its panels focused on bacterial and fungal infections that could cause sepsis, and its pipeline panel for Lyme disease.

T2 Biosystems (FRA:3T2) Headlines

No Headlines